|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
50983801
???header.onlineuser??? :
865
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"rice k c"???jsp.browse.items-by-author.description???
Showing items 1-10 of 21 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2021-07-07T05:13:15Z |
Synthesis and biological activity of fluoro-substituted pyrrolo[2,3-d]pyrimidines: The development of potential positron emission tomography imaging agents for the corticotropin-releasing hormone type 1 receptor
|
LING-WEI HSIN; Webster E.L.; Chrousos G.P.; Gold P.W.; Eckelman W.C.; Contoreggi C.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:15Z |
Synthesis of [3H](4-fluorobutyl)propyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amine: A potent radioligand for corticotropin-releasing hormone type 1 receptor
|
LING-WEI HSIN; Webster E.L.; Chrousos G.P.; Gold P.W.; Eckelman W.C.; Contoreggi C.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:15Z |
Oxygenated analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1- [2- [bis (4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents
|
Lewis D.B.; Matecka D.; Zhang Y.; LING-WEI HSIN; Dersch C.M.; Stafford D.; Glowa J.R.; Rothman R.B.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:14Z |
Development of long-acting dopamine transporter ligands as potential cocaine-abuse therapeutic agents: Chiral hydroxyl-containing derivatives of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy) ethyl]-4-(3-phenylpropyl)piperazine
|
LING-WEI HSIN; Dersch C.M.; Baumann M.H.; Stafford D.; Glowa J.R.; Rothman R.B.; Jacobson A.E.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:14Z |
The development of a potential single photon emission computed tomography (SPECT) imaging agent for the corticotropin-releasing hormone receptor type 1
|
Tian X.; LING-WEI HSIN; Webster E.L.; Contoreggi C.; Chrousos G.P.; Gold P.W.; Habib K.; Ayala A.; Eckelman W.C.; Jacobson A.E.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:14Z |
CRHR1Receptor binding and lipophilicity of pyrrolopyrimidines, potential nonpeptide corticotropin-releasing hormone type 1 receptor antagonists
|
LING-WEI HSIN; Tian X.; Webster E.L.; Coop A.; Caldwell T.M.; Jacobson A.E.; Chrousos G.P.; Gold P.W.; Habib K.E.; Ayala A.; Eckelman W.C.; Contoreggi C.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:13Z |
Synthesis and dopamine transporter affinity of chiral 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(2-hydroxypropyl)piperazines as potential cocaine abuse therapeutic agents
|
LING-WEI HSIN; Prisinzano T.; Wilkerson C.R.; Dersch C.M.; Horel R.; Jacobson A.E.; Rothman R.B.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:12Z |
A concise synthesis of (S)-(+)-1-(4-{2-[bis-(4-fluorophenyl)methoxy]-ethyl} piperazin-1-yl)-2-phenylpropan-2-ol dimaleate
|
Prisinzano T.; LING-WEI HSIN; Folk J.E.; Flippen-Anderson J.L.; George C.; Jacobson A.E.; Rice K.C. |
| 臺大學術典藏 |
2021-07-07T05:13:11Z |
The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats
|
Jutkiewicz E.M.; Wood S.K.; Houshyar H.; LING-WEI HSIN; Rice K.C.; Woods J.H. |
| 臺大學術典藏 |
2021-07-07T05:13:10Z |
Design and synthesis of 2- and 3-substituted-3-phenylpropyl analogs of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine and 1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine: Role of amino, fluoro, hydroxyl, methoxyl, methyl, methylene, and oxo substituents on affinity for the dopamine and serotonin transporters
|
LING-WEI HSIN; Chang L.-T.; Rothman R.B.; Dersch C.M.; Jacobson A.E.; Rice K.C. |
Showing items 1-10 of 21 (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page
|
